Temporal Trends in Quality of Care Among Recipients of Implantable Cardioverter-Defibrillators: Insights From the National Cardiovascular Data Registry
暂无分享,去创建一个
J. Curtis | Yongfei Wang | P. Varosy | S. Hammill | R. Lampert | J. Dodson
[1] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[2] Atul Verma,et al. Pacemaker or defibrillator surgery without interruption of anticoagulation. , 2013, The New England journal of medicine.
[3] J. Messenger,et al. The National Cardiovascular Data Registry (NCDR) Data Quality Brief: the NCDR Data Quality Program in 2012. , 2012, Journal of the American College of Cardiology.
[4] Optimal medical therapy use among patients receiving implantable cardioverter/defibrillators: insights from the National Cardiovascular Data Registry. , 2012, Archives of internal medicine.
[5] J. Curtis,et al. Implantable Cardioverter-Defibrillator Registry Risk Score Models for Acute Procedural Complications or Death After Implantable Cardioverter-Defibrillator Implantation , 2011, Circulation.
[6] M. Cheitlin. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis , 2011 .
[7] John L Sapp,et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.
[8] P. Heidenreich,et al. The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry. , 2010, Journal of the American College of Cardiology.
[9] I. Piña,et al. Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. , 2010, Heart rhythm.
[10] J. Curtis,et al. Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry. , 2010, Journal of the American College of Cardiology.
[11] Eugene Crystal,et al. Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database. , 2010, Journal of the American College of Cardiology.
[12] Wojciech Zareba,et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.
[13] Claudia Stöllberger,et al. Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.
[14] William T. Abraham,et al. Focused Update : ACCF / AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults , 2013 .
[15] J. Ornato,et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2008, Heart rhythm.
[16] B. Lindsay,et al. Review of the registry's first year, data collected, and future plans. , 2007, Heart rhythm.
[17] Harlan M Krumholz,et al. Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. , 2006, JAMA.
[18] Z. Goldberger,et al. Implantable cardioverter-defibrillators: expanding indications and technologies. , 2006, JAMA.
[19] M. Mcclellan,et al. Medicare coverage of ICDs. , 2005, The New England journal of medicine.
[20] Data Collection , 1985 .